Categories: News

OrthoMinds, LLC Provides Notice of a Data Security Event

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ALPHARETTA, Ga., March 20, 2025 /PRNewswire/ — OrthoMinds, LLC (“OrthoMinds”) is providing notice of a recent data security event. OrthoMinds is notifying clients and potentially impacted individuals of the event. This notice provides information about the event, OrthoMinds’ response, and steps potentially impacted individuals may take. OrthoMinds takes the confidentiality, privacy, and security of information very seriously.

In November 2024, OrthoMinds learned of a potential incident within its network environment. Upon discovery, OrthoMinds launched an investigation into the nature and scope of this potential incident, including remediation efforts. Upon further investigation, OrthoMinds determined that files and folders stored on certain databases may have been accessible to others outside of our organization between November 17, 2024, and November 27, 2024. As a result, OrthoMinds remediated to prevent the potential for ongoing access and began an extensive review of these files and folders to determine whether sensitive information may be impacted. Through this review, OrthoMinds determined that information which may have been involved included data related to certain services it provides to customers. Although the information varied by individual, the information involved may have included name, date of birth, medical information, health insurance information, payment card information, and Social Security number. Please note that not all data elements may have been involved for all individuals.

OrthoMinds is providing individuals with notice of this event on behalf of impacted clients and to individuals directly whose information was involved. Although OrthoMinds does not have evidence to indicate that information was subject to actual or attempted misuse to date, OrthoMinds is providing individuals whose Social Security number or payment card information may have been impacted with complimentary credit monitoring services. OrthoMinds also reviewed and enhanced existing policies and implemented additional technical security measures to further protect against similar incidents moving forward. 

Individuals who have questions or would like additional information related to this incident can visit https://orthominds.com/notice.html or contact toll-free 1-877-720-2832, Monday through Friday, 9:00 a.m. to 9:00 p.m., Eastern Time, except holidays. You can also write to OrthoMinds at 12600 Deerfield Parkway, Suite 100, Alpharetta, GA 30004.

View original content:https://www.prnewswire.com/news-releases/orthominds-llc-provides-notice-of-a-data-security-event-302407582.html

SOURCE OrthoMinds, LLC

Staff

Recent Posts

Marius Pharmaceuticals Receives Sixth U.S. Patent Allowance for KYZATREX® (testosterone undecanoate) CIII Capsules Extending Coverage to 2040

RALEIGH, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on…

8 minutes ago

Olympia Pharmaceuticals Secures $637,000 Workforce Training Grant to Boost Job Creation in Orlando

The funding will train 100 new employees at Wesley Pharmaceuticals, supporting local talent and healthcare…

8 minutes ago

Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada

TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is proud to award $85,000…

9 minutes ago

Connect Biopharma to Present at Two Upcoming Investor Conferences in June

SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect…

9 minutes ago

PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer…

9 minutes ago

Flare Therapeutics to Participate in Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology…

10 minutes ago